People who have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis should not go on GLP-1s, and neither should people with a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis
GLP-1 is responsible for: Stimulating insulin production, which pulls sugar from the blood and carries it to the cells to be used as energy Regulating the appetite and hunger signals Decreasing the release of glucagon to lower blood sugar Controlling the rate at which the stomach empties after eating Medications like Semaglutide perform the same functions as GLP-1
Consider taking natural digestive aids
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13 (1), 332336.
How might this medication affect my hunger cues and adherence to my meal plan
GLP-1 agonists carry the strongest clinical evidence for PCOS improving insulin sensitivity, reducing androgens, and supporting weight regulation